Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

Embecta (EMBC) Shares Issued (2020 - 2021)

Embecta recorded quarterly Shares Issued of -$134.5 million in Q4 2021, down 22.83% quarter-over-quarter from -$109.5 million in Q4 2020, and down 22.83% year-over-year from -$174.3 million in Q4 2020.

Embecta's Shares Issued history runs 2 years deep, the most recent figure standing at -$134.5 million for Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 121.80 Mn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 7.43 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 5.50 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 3.90 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 11.72 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 8.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 18.52 Mn
10 Embecta 197.17 Mn 3.77 Mn 127.80 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2021 -134.50 Mn
Dec 31, 2021 -134.50 Mn
Dec 31, 2020 -109.50 Mn
Dec 31, 2020 -109.50 Mn